Please assess the completion status of the following clinical trial:

Trial Title: A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients, age \>/=18 years~* Diagnosis of chronic renal anemia~* Not on dialysis~* Hemoglobin concentration \<10 g/dl~* No erythropoiesis stimulating agent (ESA) therapy during the 3 months before study start~* Estimated glomerular filtration rate (EGFR) \<60 ml/min and \>/=20 ml/min~* Adequate iron status~Exclusion Criteria:~* Transfusion of red blood cells during the previous 2 months~* Poorly controlled hypertension~* Significant acute or chronic bleeding, e.g. gastrointestinal bleeding~* Active malignant disease (except non-melanoma skin cancer)~* Hemolysis~* Hemoglobinopathies, e.g. sickle-cell disease, thalassemia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single Arm (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).